Similarly, activation of the NF-κB signaling pathway has been reported in lymphomas such as DLBCL, mantle cell lymphoma (MCL), and PTCL (29–31). This evidence concerns the gene NFKB1 and mature T-cell and NK-cell non-Hodgkin lymphoma.